Publication:

Cesium-associated hypokalemia successfully treated with amiloride

Thumbnail Image

Open/View Files

4440464.pdf (145.35 KB)

Date

2015

Authors

Published Version

10.1093/ckj/sfv017

Journal Title

Journal ISSN

Volume Title

Publisher

Oxford University Press
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Horn, Sarah, Elliot Naidus, Seth L. Alper, and John Danziger. 2015. “Cesium-associated hypokalemia successfully treated with amiloride.” Clinical Kidney Journal 8 (3): 335-338. doi:10.1093/ckj/sfv017. http://dx.doi.org/10.1093/ckj/sfv017.

Abstract

Self-treatment of cancer with cesium chloride, despite proven lack of efficacy, continues to produce serious adverse effects. Among these is hypokalemia predisposing to life-threatening arrhythmia. The mechanism of cesium-associated hypokalemia (CAH) has not been described. We report urinary potassium wasting responsive to amiloride therapy in a cancer patient with CAH, and discuss possible mechanisms.

Description

Other Available Sources

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440464/pdf/

Research Data

Keywords

cancer, cesium, hypokalemia

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

URI

http://nrs.harvard.edu/urn-3:HUL.InstRepos:17295718

Collections

HMS Scholarly Articles

Endorsement

Review

Supplemented By

Related Stories